The safety of influenza vaccine in clinically cured leprosy patients in China
Background: Leprosy is an infectious disease caused by the bacterium Mycobacterium leprae. Influenza vaccine is an important influenza prevention strategy and the preparations used display good safety and tolerability profiles. But the safety of applying influenza vaccine on the clinical cured lepro...
Saved in:
Main Authors: | Yi Zheng (Author), Li Chen (Author), Jie Zou (Author), Zheng-Gang Zhu (Author), Li Zhu (Author), Jing Wan (Author), Quan Hu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China
by: Yuemei Hu, et al.
Published: (2020) -
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China
by: Shi-Yuan Wang, et al.
Published: (2017) -
Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination
by: Zheng-Gang Zhu, et al.
Published: (2018) -
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
by: Zhaojun Mo, et al.
Published: (2017) -
Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
by: Huayue Ye, et al.
Published: (2020)